Patents by Inventor Ruehter Gerd

Ruehter Gerd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Growth hormone secretagogues
    Patent number: 7396846
    Abstract: This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the synthesis of said compounds, as well as novel processes employed in these syntheses. Also included are methods of treating a mammal which include the administration of said compounds.
    Type: Grant
    Filed: March 31, 2003
    Date of Patent: July 8, 2008
    Assignee: Eli Lilly and Company
    Inventors: Britta Evers, Ruehter Gerd, Eva Maria Martin De La Nava, Mark Joseph Tebbe
  • Growth hormone secretagogues
    Publication number: 20060167268
    Abstract: This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the synthesis of said compounds, as well as novel processes employed in these syntheses. Also included are methods of treating a mammal which include the administration of said compounds.
    Type: Application
    Filed: March 31, 2003
    Publication date: July 27, 2006
    Applicant: Eli Lilly and Company, Patent Division,
    Inventors: Britta Evers, Ruehter Gerd, Eva Martin De La Nava, Mark Tebbe
  • Growth hormone secretagogues
    Publication number: 20050240001
    Abstract: This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the synthesis of said compounds, as well as novel processes employed in these syntheses. Also included are methods of treating a mammal which include the administration of said compounds.
    Type: Application
    Filed: March 31, 2003
    Publication date: October 27, 2005
    Applicant: Eli Lilly and Company
    Inventors: Britta Evers, Ruehter Gerd, Eva Martin De La Nava, Mark Tebbe